Despite previous screening of the CRC-affected individuals using dHPLC, Sanger sequencing and MLPA, variants in the core MMR genes (MLH1, MSH2, and MSH6), comprised 22.6% (24/106) of the cases identified to carry one of the rare, predicted pathogenic variants identified in our study. This evidence concerns the gene MLH1 and colorectal carcinoma.